Which Features of Smoking Determine Mortality Risk in Former Cigarette Smokers With Diabetes? The World Health Organization Multinational Study Group

Author:

Chaturvedi Nish1,Stevens Lynda1,Fuller John H1,

Affiliation:

1. Department of Epidemiology and Public Health, University College London London, U.K.

Abstract

OBJECTIVE The effects of quitting smoking on mortality risk in individuals with diabetes is unknown and may differ from the benefits observed in the general population. We therefore determined the mortality risks in ex-smokers with diabetes, compared with subjects who have never smoked, by the number of years since quitting, the number of cigarettes smoked, and the number of years of smoking. RESEARCH DESIGN AND METHODS An international cohort study of 4,427 individuals with diabetes was studied. Baseline examinations were performed in 1975–1977 when smoking habits were determined by questionnaire. Mortality follow-up continued until 1988. RESULTS All-cause mortality risks were higher for recent quitters (1–9 years; relative risk [RR], 1.53 [95% CI 1.19–1.97]; P = 0.001) than for those who quit earlier (≥ 10 years; RR, 1.25 [95% CI 1.03–1.52]; P = 0.02), compared with subjects who have never smoked. These risks were highest in those who had smoked the longest (≥ 30 years: RR, 1.66 [95% CI 1.22–2.26]; P = 0.001; vs. 1–9 years: RR, 1.17 [95% CI 0.85–1.60]; P = 0.3). Risks were also highest in those who had smoked the most and least number of cigarettes. Adjustment for key confounders, which included a previous history of heart disease, proteinuria, and blood pressure, did not materially affect these relationships. CONCLUSIONS Quitting smoking does reduce mortality risk in ex-smokers with diabetes, but risks remain high several years after quitting and are highly dependent on the duration of smoking. Thus, individuals with diabetes who smoke should be encouraged to quit as soon as possible in the course of disease.

Publisher

American Diabetes Association

Subject

Advanced and Specialized Nursing,Endocrinology, Diabetes and Metabolism,Internal Medicine

Cited by 71 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3